1. Home
  2. CRVS vs ISOU Comparison

CRVS vs ISOU Comparison

Compare CRVS & ISOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • ISOU
  • Stock Information
  • Founded
  • CRVS 2014
  • ISOU 2016
  • Country
  • CRVS United States
  • ISOU Canada
  • Employees
  • CRVS N/A
  • ISOU N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • ISOU
  • Sector
  • CRVS Health Care
  • ISOU
  • Exchange
  • CRVS Nasdaq
  • ISOU Nasdaq
  • Market Cap
  • CRVS 459.0M
  • ISOU 391.8M
  • IPO Year
  • CRVS 2016
  • ISOU N/A
  • Fundamental
  • Price
  • CRVS $5.79
  • ISOU $8.91
  • Analyst Decision
  • CRVS Strong Buy
  • ISOU
  • Analyst Count
  • CRVS 4
  • ISOU 0
  • Target Price
  • CRVS $15.00
  • ISOU N/A
  • AVG Volume (30 Days)
  • CRVS 547.2K
  • ISOU 60.2K
  • Earning Date
  • CRVS 11-11-2025
  • ISOU 08-01-2025
  • Dividend Yield
  • CRVS N/A
  • ISOU N/A
  • EPS Growth
  • CRVS N/A
  • ISOU N/A
  • EPS
  • CRVS N/A
  • ISOU N/A
  • Revenue
  • CRVS N/A
  • ISOU N/A
  • Revenue This Year
  • CRVS N/A
  • ISOU N/A
  • Revenue Next Year
  • CRVS N/A
  • ISOU N/A
  • P/E Ratio
  • CRVS N/A
  • ISOU N/A
  • Revenue Growth
  • CRVS N/A
  • ISOU N/A
  • 52 Week Low
  • CRVS $2.54
  • ISOU $5.72
  • 52 Week High
  • CRVS $10.00
  • ISOU $9.25
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 56.88
  • ISOU 62.60
  • Support Level
  • CRVS $5.64
  • ISOU $8.25
  • Resistance Level
  • CRVS $6.09
  • ISOU $9.25
  • Average True Range (ATR)
  • CRVS 0.34
  • ISOU 0.44
  • MACD
  • CRVS -0.05
  • ISOU 0.04
  • Stochastic Oscillator
  • CRVS 50.00
  • ISOU 77.03

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About ISOU IsoEnergy Ltd. Common Shares

IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.

Share on Social Networks: